Show Summary Details
Page of

Transcranial magnetic stimulation 

Transcranial magnetic stimulation
Chapter:
Transcranial magnetic stimulation
Author(s):

Declan McLoughlin

and Andrew Mogg

DOI:
10.1093/med/9780199696758.003.0162
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 August 2019

rTMS has an increasing role as a useful investigational tool for probing neuronal circuitry in a variety of neuropsychiatric disorders. However its therapeutic value is at present less certain. The anti-depressant efficacy of rTMS has now been investigated for over 15 years and despite initial early enthusiasm there is still not clear evidence for its usefulness as a treatment in depression, reflected in the recent FDA and NICE decisions. Further research is required to identify specific brain regions in specific conditions that may be appropriate targets for treatment with rTMS, allowing tailoring of treatments for individual patients. The recent development of neuronavigational techniques using MRI imaging should aid treatment site localization. Other future research should be directed at establishing optimal rTMS parameters, e.g. the intensity, frequency and number of treatments.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.